Author: Ma Barbara
Publisher: Informa Healthcare
ISSN: 1472-8214
Source: Expert Opinion on Emerging Drugs, Vol.17, Iss.4, 2012-12, pp. : 469-492
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Emerging human papillomavirus vaccines
Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. :
Recent developments in human papillomavirus vaccines
Expert Opinion on Investigational Drugs, Vol. 13, Iss. 8, 2004-08 ,pp. :
Emerging therapies for human papillomavirus infection
Expert Opinion on Emerging Drugs, Vol. 6, Iss. 2, 2001-10 ,pp. :
Pricing Human Papillomavirus Vaccines: Lessons from Italy
By Garattini Livio > Curto Alessandro
PharmacoEconomics, Vol. 30, Iss. 3, 2012-03 ,pp. :
The Cost Effectiveness of Human Papillomavirus Vaccines: A Systematic Review
Drugs, Vol. 72, Iss. 5, 2012-03 ,pp. :